In the last decade, apoptosis (or programmed cell death) has become appreciated as an important process in the development of the cardiovascular system. Moreover, apoptosis contributes to the adaptation of the system to the environment. We are at the beginning of understanding its relevance to cardiovascular physiology and pathology. This understanding forms the key to implement apoptosis in diagnosis and therapy of cardiovascular diseases. New avenues for pharmacological intervention are expected to arise from the synergy of our knowledge about the molecular mechanisms of apoptosis, and how apoptosis integrates in the complex environment of the cardiovascular tissue. The latter strongly depends on techniques to measure apoptosis. Currently, we are facing a relative paucity in available techniques, covering both specificity and sensitivity, and furthermore allowing quantitative analysis, preferably in combination with morphology. This field, however, is rapidly evolving and is fed by the expanding knowledge about the molecular mechanisms of apoptosis. In this paper we will briefly review the available techniques to detect and / or quantify apoptosis. These methods are based on the analysis of cellular morphology, either by light-or electron microscopy, DNA fragmentation (TdT-mediated X-dUTP nick end labeling or in situ nick end labeling), or cytoplasmic and membrane changes. Furthermore, the advantages and limitations of these techniques for their use in cardiovascular research will be outlined. In the text we will refer to available reviews and protocols which discuss the techniques in more detail. The main part of this article will, however, focus on a recently introduced technique, the Annexin V-based apoptosis detection assay. The principle, characteristics, pro's and contra's of this new apoptosis detection assay will be discussed.
Introduction
edged that apoptosis plays a crucial role in homeostasis and pathology. As such, apoptosis has also been recogOver the last 10 years, there has been a steep increase in nized as a key process in the cardiovascular system. It is an research into apoptosis, mainly because it represents a new important contributor to the intact and complete developconcept of how multicellular organisms, ranging from ment of the cardiovascular system [1] and to the adaptation worms to mammals, regulate their cell numbers. In conof the cardiovascular system to its continuously changing trast to this recent interest, this concept depicts a phylodemands (e.g. stress, sports, and illness). Moreover, apopgenetic conserved form of cell death, which turned out to tosis not only turned out to be an important feature in be crucial for life in many ways. It became clear that (sub)acute cardiovascular incidence like myocardial infarcapoptosis is a process, which is accurately orchestrated and tion, hypertension and heart failure, but also in a broad organized inside the cell by gene products. To date, it is spectrum of other cardiovascular diseases ( Table 1 ). accepted that every cell type harbors the machinery to Increasing knowledge of the apoptotic pathway will help to commit suicide by apoptosis. Subsequently, it is acknowlunderstand its regulation and importance for the cardiovascular system. It may also lead to new therapeutic interventions in cardiovascular diseases. The molecular biology and biochemistry of the apoptotic their hierarchical activation [55] . These events include loss death machinery are far from being completely resolved.
of cell junctions, cell shrinkage, chromatin condensation The apoptotic process shows great diversity in the sigand margination, nuclear pyknosis and fragmentation, naling pathways by which it is induced in various cell membrane blebbing, and disassembly of the cell into types. Beyond this diversity, three functionally distinct membrane-enclosed vesicles (apoptotic bodies) [56] . Sevphases of apoptosis, common to all cell types, can be eral events have been identified on the biochemical level, distinguished [44, 45] . First, the initiation phase can be including the degradation of DNA into fragments of induced by death inducing signals, like Fas ligand and multiples of |200 base pairs, the proteolytic cleavage of tumor necrosis factor a (TNFa) [46] a lack of growth poly(ADP-ribose) polymerase (PARP) and cytoskeleton and / or survival signals, or DNA damage [47] , which may components, and the cell surface exposure of phosphadevise the cell to prepare for suicide. This preparation may tidylserine (PS). proceed in a manner, which involves a subclass of proteases, the so-called upstream or decision caspases [48] . The initiation phase will result in the activation of the second more general decision phase, in which the cell is 2. Techniques to detect apoptosis still able to make the decision to live. This phase is characterized, in most cases, by the involvement of the The original techniques to measure apoptosis employed mitochondrion [49, 50] . This organelle provides the molecthe early definition of apoptosis based on morphology. ular links between the upstream initiation phase and the During the last decade, techniques have been extended to downstream execution phase, by releasing apoptosis inducbiochemistry, molecular biology and immunology due to ing factor [51] , cytochrome c [52] , and procaspases 2, 3 our expanding knowledge about the molecular mechanisms and 9 [53, 54] . When the cell is committed to die, and thus of apoptosis (see also Table 1 ). Despite our increasing the point of no return has been passed, the third phase the insight in the initiation and decision phases of apoptosis, execution phase is activated. This phase is characterized by most of these techniques are based on what is happening the activation of the downstream or effector caspases [48] , during the execution phase (Table 2 ). In the next sections which subsequently orchestrate a sequence of events by the different techniques will be briefly outlined. For more details and protocols the reader is referred to the user's be a valuable, specific and sensitive, but merely a qualiguide: Techniques in apoptosis [57] .
tative methodology, for the detection of apoptosis [59] .
Flow cytometry (FC)

Morphological changes
FC enables the analysis of a relatively large number of 3.1. Light microscopy (LM) cells on a per cell basis in a short period of time. Assayrequired manipulation of cells is in most cases restricted to The earliest technique to detect apoptosis, and so far still a minimum. As the apoptotic cell shrinks (in contrast to the golden standard, is to study the morphology of the cell the necrotic cell which shows swelling) and subsequently by LM. Membrane blebbing, nuclear pyknosis and fragcondenses, the forward scatter decreases and sideward mentation can thus be visualized on haematoxylin and scatter slightly increases [60] . FC can be performed on eosin stained histological sections. A disadvantage of LM, cultured nonadherent as well as adherent cells. In general, however, is its low sensitivity especially, since apoptotic cells have to be in suspension for analysis. This feature cells are rapidly removed from the tissues by phagocytosis, limits its applicability as a routine technique. FC is which can be completed within 30-60 min following the therefore an excellent tool for in vitro studies, in caronset of apoptosis. In myocardium, cells with apoptotic diovascular research, but not suitable for the detection of morphology have only been observed incidentally. Hence, apoptosis in tissues, since it lacks the histological context. it is very well possible that LM reveals only the tip of the iceberg [56, 58] .
Electron microscopy (EM)
4. Cytoplasmic changes EM has the great advantage of its high specificity. The apoptotic process causes a dramatic change in the Morphological changes can be detected on a subcellular biochemistry of the cytoplasm. Some cytoplasmic paramelevel, thereby increasing sensitivity and specificity as ters have been found to be useful markers for the detection compared to LM. The cumbersome workup of the material of the apoptotic process. These include activated enzymes and the limited number of cells that can be studied, make it like caspases, ''de novo'' antigens, which arise from 21 unsuitable for routine use. Therefore, EM is considered to proteolytic action of caspases, Ca -ions, and mitochon-drial proteins, which are translocated from the mitochonchrome c [52] , and procaspases 2, 3 and 9 [53, 54] . drion into the cytosolic compartment.
Translocation of these proteins can be visualized immunologically, using specific antibodies [70, 71] . The drawback 4.1. Caspase activity of these approaches may be their low sensitivity since certain death pathways that have been recently described Caspases constitute a family of cysteine proteases that circumvent the mitochondrion and activate the downstream cleave target proteins at an aspartate residue in a recogniexecutioner directly [70] . tion sequence [48, 61] . They reside in the cytoplasm and in organelles as inactive precursors and are activated by cleavage after specific aspartate residues. Currently various 5. DNA fragmentation fluorogenic and chromogenic substrates are available for different active caspases. Most of these substrates are cell 5.1. DNA laddering impermeable and require cell and tissue homogenization to measure the caspase activity [62] . These substrates are in Degradation of nuclear DNA is one of the key features general not specific for individual caspases. So, in most of apoptosis. During apoptosis activated endonucleases cases it is difficult to attribute fluorogenic and cleave the DNA into fragments of multiples of 180-200 chromogenic activity to one specific caspase.
base pairs. These fragments appear as a DNA ladder on Caspase activity can also be measured by immunoagarose gels [72] . One limitation of this technique is the histochemical techniques using antibodies against large quantities of degraded DNA required to visualize a neoepitopes, which arise from their proteolytic activation ladder pattern. Selective amplification of DNA fragments [63] [64] [65] . Caspase activity can also be detected immunoby ligation-mediated polymerase chain reaction (PCR) logically by using antibodies, which recognize only the reduces this need [73] . A major disadvantage, however, is cleaved substrates of caspases. Recently, antibodies were the loss of tissue morphology, which render unable the described which recognize caspase cleaved cytokeratin 18 localization and identification of apoptotic cells. In some [63] , actin [64] and PARP [65] . These immunological cases apoptosis generates only high-molecular-weight approaches require fixation of the specimen.
DNA fragments, thus lowering the sensitivity of this technique [51] .
Calcium flux
DNA content by FC
Activation of the apoptotic pathways is in most cases 21 associated with an increase in cytosolic Ca concen- 21 The DNA content reflects grossly its phase in the cell tration. Such increase can be measured by using Ca cycle (G0 / G1, S / G2 and M). Apoptotic cells show a indicators like fura-2 [66] . A drawback of this technique is decreased DNA content below the G0 / G1 level. This can that the rise in cytosolic calcium is not exclusive for be measured by FC and DNA probes like propidium apoptosis and can also be associated with the activation of iodide. This technique also discriminates between apopa variety of signalling pathways, which do not lead to the tosis and necrosis. The applicability of this technique for execution of apoptosis [67] . Furthermore, a lack of sencardiovascular research is, however, limited (see Section sitivity has been observed, because, in some cases, apop-21 FC) [60, 74] . tosis proceeds in the absence of Ca changes [68] . Finally, it has to be addressed that the currently available indicators are only useful for in vitro assays.
5.3. DNA strand break labeling
Mitochondrial dysfunction
The presence of 39 hydroxyl-termini at the DNA strand breaks, characteristic of endonuclease-cleaved DNA, can A decrease in mitochondrial membrane potential is an be detected by a labeling reaction with modified nucleoearly feature of apoptotic cell death and is considered to tides, like biotin, digoxigenin -or fluorescein-labeled mark the point of no return. The mitochondrial potential dUTP. This reaction requires enzymes like terminal deoxcan be measured by a variety of fluorescent probes, which ynucleotidyltransferase (TdT) or DNA polymerase. The accumulate into the mitochondrion, as a function of the commonly used techniques are the in situ nick end labeling membrane potential. Collapse of the mitochondrial mem-(ISEL) technique using DNA polymerase [75] and the brane potential, due to apoptosis, will result in a diTdT-mediated X-dUTP nick end labeling (TUNEL) techminished ability of these fluorochromes to accumulate in nique ( Fig. 1) [76, 77] . Both techniques stain the nuclei of the mitochondria [69] . Next, the translocation of several the cells and vesicles in the tissue [78] . Recent improvemitochondrial proapoptotic proteins from the intermemments of the protocol, to exclude the nonspecific staining 21 brane space into the cytosol can be measured. These of Ca filled vesicles and RNA splicing factors, provide proteins include apoptosis inducing factor [51] , cytomore consistent staining results [4,79].
Limitations of the currently available techniques
The most important limitation of the techniques described above is that these methods measure parameters of the late execution phase of apoptosis (Table 2 ). It is expected that cells in this phase are removed from the tissue by phagocytosis. Hence, measuring apoptosis in cardiovascular tissue by these techniques harbors the risk of underestimating this process. It will be of great advantage if techniques are available which measure parameters active at the transition from the decision to the execution phase. Also, analyzing only one parameter will in most cases not result in sufficient sensitivity and specificity. This can be improved by measuring multiple parameters. A general disadvantage of the current methods is that they are single endpoint measurements, which do not provide information of the dynamics of the apoptotic process in the tissues.
Most techniques can only be performed after fixation of the material or after lysis of the cells. With respect to cardiovascular research only the TUNEL / ISEL gives . This and nonpermanent dye uptake, due to an altered membrane observation triggered us to develop a novel technique to permeability, makes flow cytometric analysis very useful measure apoptosis using Annexin V. The basis of this [74] . However, because of the toxicity of these dyes, this technique is simple, yet elegant. Annexin V is able to bind approach is less suitable for in vivo detection of apoptosis.
to PS-exposing membranes in a calcium dependent manner [81] . Conjugation of Annexin V to detectable prosthetic groups, like fluorescein and biotin, thus allows the de-6.2. Membrane changes tection of cells, which expose PS [82] [83] [84] [85] . The sensitivity and specificity of the Annexin V-based assay depends on Apoptotic cells express PS on their outer leaflet, which the biological properties of PS, and the physicochemical can be measured by derivatisation with fluorescamine and property of Annexin V to bind to PS. Below, we will subsequent analysis of the derivatized, extracted membrane address these two aspects in more detail. lipids by two-dimensional thin layer chromatography [80] . Furthermore, incorporation of the hydrophobic dye 8.1. PS localization and ( patho)physiological merocyanine 540 into the cellular membrane shows a significance loosely packed membrane, characteristic of apoptotic cells [80] . Both features indicate that the plasma membrane is
The aminophospholipid PS localizes predominantly in altered due to the apoptotic process, but obviously, the membrane leaflets facing the cytosol as was firstly shown above mentioned techniques are only suitable for in vitro for erythrocytes and platelets and later for nucleated cells analyses.
[ [86] [87] [88] . This PS asymmetry of the plasma membrane is generated and maintained by an aminophospholipid transumbilical cord artery by virtue of its anticoagulant activity locase, which transports selectively aminophospholipids [94] , which, in retrospect, can be explained by its binding from the outer to the inner leaflet, thereby creating a to and shielding of negatively charged phospholipids situation in which PS is exclusively localized to the leaflets [81, 95] . In model systems, Annexin V hardly associates facing the cytosol [86] [87] [88] .
with phosphatidylcholine and sphingomyelin (at ,5 mM 21 21 Blood platelets were the first cells for which it was Ca ) [81] , but it binds avidly to PS at 1 mM Ca , likely demonstrated that a change of PS asymmetry could be because Annexin V bears a putative binding pocket for the caused by the action of agonists like thrombin and collagen phosphoserine headgroup [96] . Once bound to the phos- [89, 90] . Stimulation of platelets results in a rise of pholipid surface, Annexin V forms two-dimensional lat- 21 cytosolic Ca , which on the one hand, inhibits the tices, which are stabilized by protein-protein interactions aminophospholipid translocase, and on the other hand, [97, 98] . Binding of Annexin V to phospholipid membranes activates a so-called scramblase, which scrambles the is reversible when calcium ions are chelated. The rates of phospholipid species symmetrically over the two leaflets association and dissociation suggest that Annexin V does [91] . Within minutes the architecture of the plasma memnot penetrate the membrane and behaves as an extrinsic brane is changed such that the platelet exposes significant membrane protein [81, 99] . Altogether, these binding feaamounts of PS at its outer plasma membrane leaflet.
tures make Annexin V an excellent tool to detect cell Comparable mechanisms appear to operate during apopsurface-exposed PS in vitro as well as in vivo. tosis giving rise to the cell surface exposure of PS [80, 92] .
Annexin V and cell surface-exposed PS, a revealing 8.2. Functions of PS in apoptosis pas de deux of apoptosis
Cell surface exposure of PS has a functional significance Using leukocytes, it was demonstrated for the first time in the removal of senescent and dying cells from the tissue.
that Annexin V discriminates between viable and apoptotic The reticuloendothelial system recognizes PS by receptors cells [82] [83] [84] . Competition experiments, using PS conand removes PS-exposing cells, like aged erythrocytes, taining phospholipid vesicles, indeed demonstrated that the from the circulation [93] . A similar scavenging system binding site for Annexin V on the apoptotic cell comprises appears to be operational in tissues, where phagocytes PS [85] . In combination with the vital dye propidium recognize and engulf PS-exposing cells through receptor iodide, it was shown that apoptotic cells expose PS while mediated processes [80] . Hence, surface-exposed PS apmaintaining their plasma membrane integrity [82] [83] [84] . The pears to be one of the signals to communicate termination Annexin V-based assay was first developed for cells in of existence to the environment, and it fulfills a distinct suspension (Fig. 2) . Later it was shown that this assay role in the physiological process to remove unwanted and could also be applied to adherent cell types [100] and in superfluous cells from the tissues. It is therefore not tissues [101] . surprising, that surface exposure of PS is an event that
The Annexin V-based assay [102] rapidly increased our occurs while the plasma membrane integrity is uncomknowledge about the embedding of PS exposure in the promised. If this would not be the case, the PS-exposing apoptotic process. The accumulated experimental data cell would leak its proinflammatory content into the tissue, point towards a position at the transition from the decision eliciting undesirable inflammatory reactions.
to the execution phase, hence early in the execution phase [103] before morphological changes of the nucleus can be 8.3. Annexin V and its binding to PS detected [104] . The exposure of PS does not depend on the involvement of the nucleus, but requires the activation of 21 Annexin V was originally isolated from the human caspase 3 and a Ca flux over the plasma membrane [105]. Next, it turned out that the exposure of PS is under reperfusion time to 90 min leads to a massive increase in the control of the Bcl-2 checkpoint, in case the mitochAnnexin V positive cardiomyocytes in the area at risk (Fig.  ondrion participates in the death process [85] . These 3A). In most cardiomyocytes only plasma membrane insights were generated by in vitro experiments using staining was observed (Fig. 3B) , and different stages of cultured or isolated cells. Recently, it was demonstrated apoptosis were observed in the cardiomyocytes, similar to that the Annexin V assay could be used in vivo by injecting the findings reported from in vitro assays. Annexin V-biotin into the bloodstream of living mouse
In the contralateral areas of the heart and in hearts of embryos [101] . In vivo Annexin V-biotin stains cells in sham-operated controls, no Annexin V positive carvarious phases of apoptosis ranging from the early phase in diomyocytes were visualized. Moreover, in mouse hearts which no morphological changes of the nucleus are subjected to 30 min of ischemia and 90 min of reperfusion, detected on the EM level, until the late phase with no positive cardiomyocytes were observed after application pyknotic nucleus and condensed cytoplasm [101] . The of an Annexin V mutant, which lacks the ability to bind PS. combination of the Annexin V-based assay and the TUNEL Altogether, we conclude that the Annexin V-based assay is method revealed the presence of three subpopulations of a specific, sensitive, and reliable method to detect apopapoptotic cells in tissues. Firstly, Annexin V positive / tosis in the heart in vivo. Furthermore, we demonstrated TUNEL negative cells which are in the early execution that ischemia / reperfusion rapidly elicits programmed cell phase. Secondly, both TUNEL and Annexin V positive death in a substantial region of the area at risk in the cells, which are in the late stage of the execution phase. And thirdly, Annexin V negative / TUNEL positive cells, which are located in phagolysosomes [106] . The latter subpopulation reflects cells, which started to execute apoptosis well before the time point of the experiment. This could range from hours to days. These data indicate that the Annexin V-based assay is so far the most sensitive technique to detect ongoing apoptosis.
Use of Annexin V in detection of apoptosis in the heart
To date, the TUNEL assay or DNA gel electrophoresis are the most utilized techniques to detect apoptosis in the heart [107] [108] [109] [110] . Both techniques identify events occurring late in the apoptotic process, thus detecting apoptosis approximately 3 h after the onset of ischemia [110] . It has been argued that TUNEL and / or DNA laddering are suitable to assess neither the full extent of apoptosis nor the early kinetics of apoptosis (see above section). An insight into these is, however, indispensable to judge whether intervention with agents interfering with the apoptotic pathway is an option and whether such option is therapeutically of value. The Annexin V-based assay could provide answers to these questions. Therefore we injected labeled Annexin V intraarterially in an established ischemia and reperfusion model of the mouse heart in vivo [111] .
After 15 min of ischemia followed by 30 min of reperfusion, some Annexin V positive cardiomyocytes were already observed in the area at risk. Specifically, stained cardiomyocytes could be observed, which also showed murine heart. These findings bear important consequences necrosis. Until the underlying mechanism is resolved a for future intervention strategies since the observed kinetcombination of the Annexin V-based assay and a DNA ics suggest that the intervention window is narrow. Thus, marker such as propidium iodine, which will stain DNA if only agents should be considered which interfere before the plasma membrane is perturbed, will increase the the point of no return. specificity of the assay. Until now, such a combination can Annexin V also offers the possibility to monitor apoponly be performed in vitro due to the toxicity of the DNA tosis in vivo by noninvasive imaging techniques. Such an dye. In vivo, a combination with assays for substances, approach has been described previously in a cardiac which accumulate in necrotic cells, like fibronectin [113] transplant model in rats [22] . We explored this technique in or IgG [114] , may increase the specificity of the assay. our murine ischemia / reperfusion model by using fluoresAnother possible pitfall of the administration of Annexin cent-labeled Annexin V, and detected the apoptotic cells V in mammals results from our relative lack of knowledge using a surgical microscope equipped with a fluorescence of the physiological function of Annexin V. Studies condetection system. Ischemia and reperfusion resulted in a centrated around endogenous Annexin V, do suggest that time dependent increase of Annexin V labeling in the area the PS recognition of Annexin V also forms the basis for its at risk, suggesting that continuous in vivo imaging is physiological function. Since Annexin V is widely distribpossible. Next, we evaluated the use of technetium labeled uted in mammals, it is conceivable that administration of Annexin V and nuclear single photon emission computed exogenous Annexin V may interfere with physiological tomography (SPECT) imaging for detection of apoptosis processes in which Annexin V is involved, such as the under similar conditions. Again an enhanced uptake of blood coagulation, inflammation and phagocytosis, alAnnexin V-technetium was observed in the area at risk in though such interference has never been reported. contrast to sham-operated controls where no uptake was
The Annexin V-based assay allows also the performance detected. These data suggest that in vivo imaging of of kinetic experiments. Preliminary experiments have apoptosis in the heart is possible with Annexin V conjushown that the Annexin V-based assay allows real time gates. Whether such a technique is also suitable for patients imaging of apoptosis since no fixation or other artifactual with myocardial infarction remains to be established.
handling is required. In the ischemia and reperfusion model administration of Annexin V-fluorescence isothiocyanate (FITC) to the circulation results in the visualiza-10. Sensitivity, specificity and applicability of the tion of the appearance of apoptotic cells in the area at risk.
Annexin V assay
In conclusion, the Annexin V-based assay seems to be a valuable technique to detect apoptosis in cardiovascular As already discussed, detection of apoptosis with Anresearch. So far, it is a very sensitive technique to detect nexin V is a rather simple and easily applicable technique. apoptosis and applicable in a variety of settings, including The assay is one of the most sensitive methods because it in vivo. Its applicability to detect apoptosis in patients with detects apoptosis in the early execution phase (Table 2) . cardiovascular diseases remains to be established. Moreover, the assay is versatile since it can be applied in vitro, ex vivo and even in vivo. Theoretically, the sensitivity of the Annexin V-based assay could be impaired by Acknowledgements endogenous Annexin V, which may compete with administered Annexin V. However, so far such a competition was Waander L. van Heerde is a research fellow of the not observed. This may be explained by the physicoNetherlands Heart Foundation and supported by grant chemical characteristics of Annexin V to form a dynamic D96-025. two-dimensional lattice on the cell surface in which exogenous Annexin V is easily incorporated.
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